Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 17:2021:6633386.
doi: 10.1155/2021/6633386. eCollection 2021.

Molecular Insights into the Potential of Extracellular Vesicles Released from Mesenchymal Stem Cells and Other Cells in the Therapy of Hematologic Malignancies

Suliman A Alsagaby  1
Affiliations
Review

Molecular Insights into the Potential of Extracellular Vesicles Released from Mesenchymal Stem Cells and Other Cells in the Therapy of Hematologic Malignancies

Suliman A Alsagaby. Stem Cells Int. .

Abstract

Hematologic cancer encompasses the heterogeneous group of neoplasms that affect different stages of blood cell linages. Despite the significant improvements made in the new modalities of anticancer therapy, many forms of blood cancer remain untreatable, putting the afflicted patients at high risk of death. Therefore, there has been an urgent need for novel therapy to improve the clinical outcomes of patients with blood cancer. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have been reported to possess an anticancer activity. This review discusses (i) the therapeutic potential of MSC-EVs against blood cancer, (ii) the possibility of using EVs from sources other than MSCs as a mean for blood cancer vaccination and drug delivery, and (iii) areas to be optimized for MSC-EV-based clinical application on blood malignancies.

PubMed Disclaimer

Conflict of interest statement

The author declares that there is no conflict of interest.

Figures

Figure 1
Figure 1
Biogenesis of extracellular vesicles (EVs). Section (a) describes the biosynthesis of exosomes, and section (b) shows the generation of microvesicles (MVs).
See this image and copyright information in PMC

References

    1. Buchsbaum R. J., Schwartz R. S. Cellular origins of hematologic neoplasms. The New England Journal of Medicine. 1990;322(10):694–696. doi: 10.1056/NEJM199003083221011. - DOI - PubMed
    1. Taylor J., Xiao W., Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130(4):410–423. doi: 10.1182/blood-2017-02-734541. - DOI - PMC - PubMed
    1. Alsagaby S. A., Brennan P., Pepper C. Key molecular drivers of chronic lymphocytic leukemia. Clinical Lymphoma Myeloma and Leukemia. 2016;16(11):593–606. doi: 10.1016/j.clml.2016.08.008. - DOI - PubMed
    1. Alsagaby S. A. Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia. Oncology Reviews. 2019;13(2) doi: 10.4081/oncol.2019.435. - DOI - PMC - PubMed
    1. Russo D., Garcia-Gutierrez J. V., Soverini S., Baccarani M. Chronic myeloid leukemia prognosis and therapy: criticisms and perspectives. Journal of Clinical Medicine. 2020;9(6):p. 1709. doi: 10.3390/jcm9061709. - DOI - PMC - PubMed

LinkOut - more resources